Home monitoring for pulmonary fibrosis
Part of Lungs & breathing clinical trials.
This trial studies whether using a home monitoring program helps people with pulmonary fibrosis track their condition. It aims to make care easier and catch changes early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with pulmonary fibrosis, a type of lung scarring, by a team of lung specialists.
- You are 18 years or older.
- You can speak, read, and write in Dutch.
- You have access to the internet at home.
- Your doctor believes you are likely to live at least one year from now.
- You have not used a home monitoring program for pulmonary fibrosis before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people with scarring lung disease (pulmonary fibrosis) in Ireland. It aims to better understand and care for the condition, especially in families. The study will look at medical data and may help improve diagnosis and treatment.
This trial tests whether a digital self-management program (using a smartphone or tablet) helps people with fibrotic interstitial lung disease better manage their symptoms and quality of life. If you have this lung condition and can use a mobile device, this study could offer you extra support at home.
This study builds a community registry to learn about people affected by pulmonary fibrosis and related lung conditions, including patients, caregivers, and close family. By joining, you help researchers better understand needs and experiences in the real world.
This trial tests a new way to organize follow-up visits for people with interstitial lung disease (a group of lung conditions). It aims to make care simpler and more effective for patients who are already on treatment.
This study tests an online programme called I-IMPACT that combines exercise and education for adults with interstitial lung disease (ILD). It aims to see if the programme is practical and helpful for people with ILD.
This study tests whether using remote monitoring devices and apps at home can help track your lung health between clinic visits. It may help you stay connected with your care team and catch changes sooner.
Hear when a new Pulmonary Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.